Skip to content

Clinical trials

Phase 2/3 Leukemia trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2/3 Status: Unknown status Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20141
20163
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status8

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Nanfang Hospital, Southern Medical University3
European Organisation for Research and Treatment of Cancer - EORTC1
Grupo Argentino de Tratamiento de la Leucemia Aguda1
National Research Center for Hematology, Russia1
Peking University People's Hospital1
University Hospital Muenster1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia8
Precursor Cell Lymphoblastic Leukemia-Lymphoma4
Leukemia, Myeloid, Acute2
Leukemia, T-Cell2
Congenital Abnormalities1
Leukemia, B-Cell1
Leukemia, Basophilic, Acute1
Leukemia, Eosinophilic, Acute1
Leukemia, Erythroblastic, Acute1
Leukemia, Megakaryoblastic, Acute1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.